Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis.
about
The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific TreatmentsThe Relationship Between Mental Health, Disease Severity and Genetic Risk for Depression in Early Rheumatoid ArthritisEffects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data.Are we missing the diagnosis of depression in patients with rheumatoid arthritis at a tertiary care facility?A goal management intervention for polyarthritis patients: rationale and design of a randomized controlled trial.Depression in patients with rheumatoid arthritis: description, causes and mechanisms.Effects of centrally administered etanercept on behavior, microglia, and astrocytes in mice following a peripheral immune challenge.The challenging interplay between rheumatoid arthritis, ageing and comorbidities.Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment.Factors that influence fatigue status in patients with severe rheumatoid arthritis (RA) and good disease outcome following 6 months of TNF inhibitor therapy: a comparative analysisElevated immune-inflammatory signaling in mood disorders: a new therapeutic target?Preliminary report on a study of health-related quality of life in patients with rheumatoid arthritisSignificance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.Depression and Insomnia in Patients With Psoriasis and Psoriatic Arthritis Taking Tumor Necrosis Factor AntagonistsA Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response Modifiers.Remission from Depression among Adults with Arthritis: A 12-Year Followup of a Population-Based Study.Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study.The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review.Non-inflammatory Causes of Pain in Patients with Rheumatoid Arthritis.Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways.Depressive symptoms predict future simple disease activity index scores and simple disease activity index remission in a prospective cohort of patients with early inflammatory polyarthritis.Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?Inflaming depression.Health-related quality of life and depression in a sample of Latin American adults with rheumatoid arthritis.A blind randomized controlled trial of cognitive versus behavioral versus cognitive-behavioral therapy for patients with rheumatoid arthritis.Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis.Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review.The relationship between disease activity and depressive symptoms severity and optimism--results from the IMPROVED study.Correlation of articular involvement, skin disfigurement and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample.Emerging drugs for major depressive disorder: an update.Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis.Twelve years' experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practice.Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial.Depressive mood and low social support are not associated with arthritis development in patients with seropositive arthralgia, although they predict increased musculoskeletal symptoms.The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan
P2860
Q26783012-F4788E0B-B73B-44FF-BA77-0868764ADD82Q30491102-7FD64F11-DC02-4D23-8CB2-E4CF11A368B3Q30984829-0418EE96-CCCA-46D3-9082-3D5D31ABEE72Q33690283-70647DC7-FD8C-4DB8-A4F2-40017C85F8E9Q34939514-12617826-D44A-4D02-AD77-27F894E2797DQ35638534-DDDAE701-5DA6-4169-AE83-BA17DD756266Q35647379-30A33221-2E9D-4B38-B720-2D8D3E5F317AQ36000249-C863D6E0-8ABE-44BE-ACDA-6A37C52AE99EQ36033361-D78846D0-13D4-482D-B266-F632A3D4617AQ36220823-BF1C2B0D-F0B6-4DA2-AE2D-DD8051D66D20Q36502629-909607E8-005F-4F27-AA52-636F7B0B0D28Q36568759-7F2FE492-3A8E-45F6-95B4-13BD192B9583Q36706945-E8A51C77-A7EB-4EC7-A04D-A337A3F5E280Q36988833-8C12D203-C7BD-4C42-9204-5C4184C61EE1Q37100388-467C115D-66C9-438B-96FC-450426C19687Q37579406-8CABAF35-2437-4D40-AAB2-78A650E49C0BQ37689724-848CE3CF-DF34-4495-9251-1285E28E7744Q38067080-217F2173-0D9C-46AD-8B2A-20AB12F74AAAQ38813037-58726ABC-490F-418D-AE63-FB386AB92101Q38895581-3C69D4DE-C4AC-4F89-981D-AB99FAE6827CQ38981346-467D57C8-8322-46ED-B7DD-DC752E4081AFQ40847456-F784FC86-B184-45DE-9215-E9309CE38B49Q42878193-40D83525-B378-4FC6-A99C-CBB195DCB711Q45004190-659DFBD4-D21C-4AC6-8B82-665DAA2AABDAQ45120829-1749ABB9-B563-480A-AE31-FFB1575BB712Q46341059-237B114C-258B-4A1B-A088-3325EFDBBEA7Q47563427-EC2651A7-7331-40F3-A1C9-8CDC0221C0B2Q47996637-1943AF51-D556-4EF8-9CB9-3FE9D052C2A6Q48344320-9746D4DD-F242-4353-B3BB-35DEDF0D3D73Q48692644-1AD578B1-E485-4E2A-BE49-5C74591AEDBEQ48762724-D5FE53E2-653B-49A7-BD10-1DEF3D5D5036Q53650686-E70F7C99-C397-41F4-936B-A1B96586609BQ55223606-73FFBD1E-4C97-4BBE-957A-5D008F59B418Q55710198-2B7D9956-1BBA-4A2A-937E-55C84755C92DQ58204340-0218D70F-622A-47E4-997A-9EB2376CF295
P2860
Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Improvements in patient-report ...... ve early rheumatoid arthritis.
@en
Improvements in patient-report ...... ve early rheumatoid arthritis.
@nl
type
label
Improvements in patient-report ...... ve early rheumatoid arthritis.
@en
Improvements in patient-report ...... ve early rheumatoid arthritis.
@nl
prefLabel
Improvements in patient-report ...... ve early rheumatoid arthritis.
@en
Improvements in patient-report ...... ve early rheumatoid arthritis.
@nl
P2093
P2860
P356
P1433
P1476
Improvements in patient-report ...... ve early rheumatoid arthritis.
@en
P2093
Amitabh Singh
Bruce Freundlich
Jeffrey Melin
Joern Kekow
Rezaul Khandker
Robert Moots
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEQ327
P577
2010-11-08T00:00:00Z